On January 17, 2024, Epicore Biosystems, Inc. closed the transaction. The transaction included participation from new investors, Pegasus Tech Ventures, Inc. and Denka Company Limited. The company has raised $1,539,999 pursuant to exemption provided under Regulation D from 2 investors
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,295 JPY | +0.37% | +3.38% | -8.05% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.05% | 1.26B | |
+5.14% | 103B | |
-5.63% | 63.04B | |
+39.52% | 39.06B | |
+12.91% | 37.58B | |
+7.41% | 33.24B | |
+6.85% | 19.22B | |
+12.86% | 16.83B | |
+16.93% | 14.96B | |
+7.73% | 15.03B |
- Stock Market
- Equities
- 4061 Stock
- News Denka Company Limited
- Epicore Biosystems, Inc. announced that it has received $10.006315 million in funding from Pegasus Tech Ventures, Inc., Denka Company Limited